CAS 115103-54-3: Tiagabine
Description:Tiagabine is a pharmaceutical compound primarily used as an anticonvulsant in the treatment of epilepsy. It functions as a selective inhibitor of the neurotransmitter gamma-aminobutyric acid (GABA) reuptake, thereby increasing GABA levels in the synaptic cleft and enhancing inhibitory neurotransmission. This mechanism contributes to its effectiveness in controlling seizures. Tiagabine is typically administered orally and is known for its relatively high bioavailability. The substance is characterized by its molecular formula, which includes carbon, hydrogen, nitrogen, and oxygen atoms, reflecting its organic nature. It is generally well-tolerated, although potential side effects may include dizziness, fatigue, and cognitive disturbances. Tiagabine's pharmacokinetics involve hepatic metabolism, primarily through cytochrome P450 enzymes, and it has a moderate half-life, necessitating multiple daily doses for sustained therapeutic effects. As with any medication, it is essential for patients to follow prescribed dosages and consult healthcare professionals regarding potential interactions and contraindications.
Formula:C20H25NO2S2
InChI:InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1
InChI key:InChIKey=PBJUNZJWGZTSKL-MRXNPFEDSA-N
SMILES:O=C(O)C1CN(CCC=C(C=2SC=CC2C)C=3SC=CC3C)CCC1
- Synonyms:
- (3R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-buten-1-yl]-3-piperidinecarboxylic acid
- (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid
- (R)-Tiagabine
- 1-[4,4-Bis(3-Methylthiophen-2-Yl)But-3-En-1-Yl]Piperidine-3-Carboxylic Acid
- 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3R)-
- 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, (3R)-
- 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, (R)-
- Gabatril
- No 050328
- No 328
- See more synonyms
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3R)- REF: IN-DA000GAYCAS: 115103-54-3 | 99% | 104.00 €~618.00 € | Fri 21 Mar 25 |
![]() | Tiagabine REF: 7W-GP9315CAS: 115103-54-3 | - - - | To inquire | Mon 24 Mar 25 |
![]() | Tiagabine REF: TM-T2407CAS: 115103-54-3 | 99.24% | To inquire | Fri 28 Mar 25 |
![]() | Tiagabine REF: TR-T221660CAS: 115103-54-3 | - - - | 422.00 € | Mon 31 Mar 25 |
![]() | Tiagabine REF: 3D-FT146887CAS: 115103-54-3 | Min. 95% | - - - | Discontinued product |

3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3R)-
Ref: IN-DA000GAY
10mg | 111.00 € | ||
25mg | 150.00 € | ||
50mg | 275.00 € | ||
100mg | 618.00 € |

Ref: 7W-GP9315
Undefined size | To inquire |

Tiagabine
Ref: TM-T2407
5mg | 44.00 € | ||
10mg | 55.00 € | ||
50mg | To inquire | ||
1mL*10mM (DMSO) | 56.00 € |

Tiagabine
Ref: TR-T221660
5mg | 422.00 € |

Tiagabine
Controlled ProductRef: 3D-FT146887
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |